Extendicare's CBI Integration Kicks In: Home Health Scale Drives a Step-Change in Results, but Margin Investment and Missing Rate Hikes Temper the Quarter

A Quarter Defined by Acquisition and Integration

Extendicare’s second-quarter results mark a decisive inflection point. The CBI acquisition closed on April 1, making Q2 the first full quarter of contribution. Revenue jumped 59.4% to $611M, adjusted EBITDA rose 71.7% to $68.3M, and home healthcare volume (ADV) more than doubled organically plus acquired. The company also issued $450M of 5-year unsecured notes at 4.345%, establishing a BBB-rated investment-grade capital structure, and repaid higher-cost mortgages, bringing leverage to 2.5x — well inside the original 3.3x outlook. CEO Michael Guerriere summed it up: “Our second quarter results reflect the successful execution of our acquisition strategy over the last 18 months.”

This is not just a numbers story. The acquisition of CBI was transformational in scope, adding ~12 million annual hours of care and expanding Extendicare’s footprint in Western Canada. Management remains confident in “the strength of the platform we have built,” — Michael R. Guerriere, President and CEO · 2026-08-07 and the integration is progressing methodically. CFO David Bacon noted that on the CBI side, the focus is on “planning for a couple of elements of that transaction where there is still some transitional services.” — David E. Bacon, Executive Vice President and CFO · 2026-08-07 This careful, region-by-region approach – previously used for Closing the Gap – is designed to minimize disruption.

Home Health: Growth Meets Margin Pressure

The home health segment was the star performer and the source of the quarter’s only blemish. Revenue rose by $202M year-over-year, NOI jumped 117.8%, but NOI margins fell 60 basis points to 12.9%. The decline is attributed to two factors: absence of a 2026 Ontario rate increase and a deliberate step-up in back-office investment to support the unprecedented organic growth. On the Q&A, David explained that the back office had largely remained flat through 2024-25 despite high-teen growth, and the investment was needed to “get back to an equilibrium.” He said, “it is mostly people. And the related technology costs that come with upsizing that back office.” — David E. Bacon, Executive Vice President and CFO · 2026-08-07 The step-function increase in headcount is now largely complete, and management expects margins to recover and expand over time, reiterating a long-term view that the business should run at 13%+.

Demand growth remains the core driver. The company continues to see strong organic volume growth, but management tempers expectations: “We continue to expect that the underlying market growth will moderate over time to a long run average of approximately 6% to 8% on an annualized basis.” — Michael R. Guerriere, President and CEO · 2026-08-07 This is a consistent theme from prior quarters. In the February 2026 call, Michael noted, “The pace of growth continues to surprise us, frankly,” — Michael Guerriere, President and CEO · 2026-02-27 and the same sentiment echoes today.

LTC and Managed Services: Stable but Less Catalytic

Long-term care delivered solid fundamentals: NOI grew 23.9%, margins expanded 110 bps to 12.7%, supported by funding enhancements and preferred occupancy. The company continues to execute its Ontario redevelopment program through the Axium JV, with a new 320-bed home opened in Ottawa and the sale of the Sudbury project into the JV. Mike highlighted the pipeline: “We are on track to open 4 new homes in 2027. Representing a further 832 beds.” — Michael R. Guerriere, President and CEO · 2026-08-07 Managed services remain a stable earnings contributor, with NOI up $0.2M despite lower management contract beds, thanks to strong SGP client growth.

Capital Structure and Cash Flow: A Stronger Base

The balance sheet transformation is a key part of the story. The new unsecured credit facility and notes offering reduced the weighted average interest rate by 80 bps to 4.4% and extended maturity. Pro forma net debt to EBITDA stands at 2.5x, a significant deleveraging from the expected 3.3x at announcement. This gives Extendicare flexibility to consider additional M&A – though management paused future deals to focus on integration, they expressed openness to “opportunistic” transactions. On the call, Tal Woolley asked about the elevated cash balance, and David indicated they expect to “carry lower balances” — David E. Bacon, Executive Vice President and CFO · 2026-08-07 and redirect cash to pay down the revolver, further deleveraging.

The company also addressed its reporting metrics, with David noting a likely shift away from AFFO toward EBITDA and a cleaner cash flow measure to reduce volatility. This is a meaningful change in how the market should value the business.

The CBI acquisition contributed adjusted EBITDA of $18.5 million... our pro forma debt to adjusted EBITDA is approximately 2.5x at quarter end, well ahead of our original estimate of 3.3x post the CBI acquisition at the time we announced the transaction last year.

Home Health is now the primary growth engine, and the Long Term Care Home redevelopment program provides long-term visibility. The broader market is clearly voting for this strategy, as evidenced by the strong tape response. But the quarter also underscores the delicate balance: scaling fast brings operational costs, and dependence on government funding creates near-term volatility. The absence of an Ontario rate increase is a reminder of that dependency, and while management expects certain geographies to eventually get rate relief, the timing remains uncertain.